Teladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of “Hold” from Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has earned an average rating of “Hold” from the twenty ratings firms that are presently covering the firm, Marketbeat reports. Fourteen research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $12.31.

A number of equities analysts have recently commented on the stock. DA Davidson decreased their price target on shares of Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a report on Thursday, August 1st. Evercore ISI reduced their target price on shares of Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. Truist Financial reduced their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a report on Friday, August 2nd. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a report on Friday, August 2nd. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price target on shares of Teladoc Health in a report on Tuesday, August 20th.

Insider Activity at Teladoc Health

In related news, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the transaction, the insider now directly owns 33,667 shares of the company’s stock, valued at approximately $274,049.38. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the firm’s stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the sale, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Thomas Mckinley acquired 4,000 shares of Teladoc Health stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $7.69 per share, with a total value of $30,760.00. Following the completion of the purchase, the director now owns 39,077 shares in the company, valued at approximately $300,502.13. The disclosure for this purchase can be found here. Insiders sold a total of 57,377 shares of company stock valued at $438,054 in the last three months. Company insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Institutional investors and hedge funds have recently bought and sold shares of the company. ICA Group Wealth Management LLC bought a new stake in Teladoc Health during the 4th quarter valued at about $28,000. Signaturefd LLC increased its stake in Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,715 shares in the last quarter. International Assets Investment Management LLC bought a new stake in Teladoc Health during the 2nd quarter valued at about $29,000. Doheny Asset Management CA bought a new stake in Teladoc Health during the 2nd quarter valued at about $46,000. Finally, SageView Advisory Group LLC bought a new stake in shares of Teladoc Health in the first quarter worth approximately $48,000. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Stock Performance

NYSE TDOC opened at $9.18 on Tuesday. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $22.54. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. The stock has a market capitalization of $1.57 billion, a PE ratio of -6.51 and a beta of 0.90. The company’s 50 day simple moving average is $7.93 and its two-hundred day simple moving average is $10.58.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.08. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. The business had revenue of $642.44 million for the quarter, compared to analysts’ expectations of $649.34 million. Analysts predict that Teladoc Health will post -1.18 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.